Novo Nordisk grants Taiwanese firm access to smart pen data
A new collaboration between Novo Nordisk and Health2Synch enables users of the latter company’s app solution to automatically register data about their insulin treatments when using Novo’s smart injector pens.
by MIKKEL AABENHUS HEMMINGSEN, translated by daniel pedersen
Novo Nordisk’s smart insulin pens, Novopen 6 and Novopen Echo Plus, will be able to transfer insulin dose logs directly to app Health2Synch in the future, says the app’s developer going by the same name in a press release.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Novo Nordisk launches smart insulin pens in the UK
For subscribers
